SCHEMBL7651562

SCHEMBL7651562

CCOC(=O)Cc1ncccc1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.53
MAPK1 P28482 2/20 0.53
SMN1; SMN2 Q16637 5/20 0.49
LMNA P02545 2/20 0.48
TRPM8 Q7Z2W7 1/20 0.47
KDM4E B2RXH2 3/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 2/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
HPGD P15428 2/20 0.45
HTT P42858 1/20 0.45
SQOR Q9Y6N5 1/20 0.44
RECQL P46063 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPC1 O15118 1/20 0.43
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132049 0.81 MAPT (0.52) MAPTMAPK1SMN1; SMN2LMNAKDM4E
SCHEMBL2390130 0.80 CYP4F2 (0.51) MAPTMAPK1SMN1; SMN2LMNATRPM8
SCHEMBL6344652 0.80 MAPT (0.54) MAPTMAPK1SMN1; SMN2LMNAKDM4E
SCHEMBL9963987 0.80 LMNA (0.41) SMN1; SMN2LMNAKDM4EL3MBTL1ALDH1A1
SCHEMBL7651566 0.80 SMN1; SMN2 (0.49) MAPTMAPK1SMN1; SMN2LMNATRPM8
SCHEMBL2589045 0.79 MAPT (0.61) MAPTMAPK1SMN1; SMN2LMNAKDM4E
SCHEMBL30177224 0.79 MAPT (0.61) MAPTMAPK1SMN1; SMN2LMNAKDM4E
SCHEMBL7010780 0.79 MAPT (0.53) MAPTMAPK1SMN1; SMN2LMNATRPM8
SCHEMBL7052623 0.78 PPIA (0.53) MAPTMAPK1L3MBTL1ALDH1A1TSHR
SCHEMBL4061267 0.78 MAPT (0.52) MAPTMAPK1SMN1; SMN2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed
EP-1033366-A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists Pfizer Products Inc. (US) 2000-09-06 EP disclosed